Snap Inc. has filed a formal response to the claims made in a Snapchat fentanyl overdose deaths lawsuit brought by the parents of children who tragically died from fentanyl-laced pills acquired through the social media platform. In its response, the company contests the allegations that Snapchat’s features promote or facilitate the sale of counterfeit drugs, particularly to minors and young adults. The lawsuit, filed in Los Angeles Superior Court, includes claims from Rhonda Burris and numerous relatives of 27 deceased users. The plaintiffs allege that Snapchat’s app features encourage, advertise, and willfully ignore the illicit drug sales that have contributed to the overdose deaths of their loved ones. Snap Inc. Challenges the Allegations In its filing, Snap Inc. strongly denies these accusations, asserting that many of the decedents had a history of drug use, were involved in drug dealing, or had obtained drugs through other channels. Snap’s legal team pointed out that, based on initial evidence, at least 18 of the 27 deceased individuals had been involved in drug dealing. Furthermore, the company stated that nearly all of the deceased had prior histories of drug use known to their families. “Snap raises these facts not to diminish the tragic circumstances
Read More